SCHEMBL24979652

SCHEMBL24979652

CC(C)(C)S(C)(=O)=NC(=O)C(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ATR Q13535 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25249286 0.81 ATR (0.31) ATR
SCHEMBL26960982 0.81 ATR (0.31) ATR
SCHEMBL26960981 0.81 ATR (0.31) ATR
SCHEMBL16806506 0.78 ATR (0.53) ATR
SCHEMBL17451536 0.78 ATR (0.42) ATR
SCHEMBL19501553 0.73
SCHEMBL25882254 0.68 ATR (0.41) ATR
SCHEMBL24109605 0.67 ATR (0.66) ATR
SCHEMBL17937434 0.67 ATR (0.43) ATR
SCHEMBL17527114 0.66 ATR (1.00) ATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230012782-A1 NOVEL SULFILIMINES OR SULFOXIMINES CONTAINING FUNGICIDAL HETEROCYCLIC COMPOUNDS PI INDUSTRIES LTD. (IN) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230012782-A1 NOVEL SULFILIMINES OR SULFOXIMINES CONTAINING FUNGICIDAL HETEROCYCLIC COMPOUNDS SULT1E1, SULT1A1, STS ATR 1600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.